Close Menu

NEW YORK (360Dx) – Mayo Clinical Laboratories and Numares said today that they are collaborating to develop clinical diagnostic tests that use nuclear magnetic resonance spectroscopy to detect cardiovascular disease, kidney disease, liver cancer, and other diseases.

Financial and other terms of the deal were not disclosed.

The collaborators said that they anticipate developing tests that measure and analyze metabolic constellations, or clusters of risk factors, derived from clinical diagnostic tests performed on patient samples, such as blood or urine.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.